House Democrats introduced a bill that aims to protect the patient protections enshrined in the Affordable Care Act.
A day after the Trump administration reversed course on the Affordable Care Act (ACA) by telling the Fifth District Court of Appeals it agreed with a lower court’s opinion that the entire law is unconstitutional, House Democrats introduced a bill that aims to protect the patient protections enshrined in the ACA.
Called the “Protecting Pre-Existing Conditions & Making Health Care More Affordable Act of 2019,” the bill is an effort to lower health insurance premiums by expanding eligibility for premium tax credits beyond 400% of the federal poverty line and increasing the size of tax credits for all income brackets. The legislation also creates a national reinsurance program to help cover care for patients with costly conditions, and offers funding to states to establish their own state-based marketplaces.
The bill was introduced Tuesday by Energy and Commerce Chairman Frank Pallone Jr, D-New Jersey; Ways and Means Chairman Richard Neal, D-Massachusetts; and Education and Labor Chairman Bobby Scott, D-Virginia.
“This comprehensive proposal follows through on our commitment to make healthcare more affordable and to defend critical protections for the more than 133 million Americans living with pre-existing conditions,” Pallone said in a statement.
Late Monday, the Department of Justice said it now backs the December 2018 ruling from a district court judge in Texas that said the entire ACA is invalidated without the individual mandate, which was removed when Congress reduced the penalty to $0.
The bill introduced Tuesday includes:
Second CRL for Rivoceranib/Camrelizumab for Unresectable HCC
March 21st 2025Despite resubmitting after an initial complete response letter (CRL) due to manufacturing issues, the combination therapy received a second CRL as a frontline therapy for unresectable hepatocellular carcinoma (HCC).
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen